Results 131 to 140 of about 202,515 (300)

Do you give neuroprotective/alternative drugs to manage normal tension glaucoma?

open access: yesPhilippine Journal of Ophthalmology, 2019

Nilo Vincent FlorCruz, MD   +2 more
doaj  

Eye-tracking reading patterns across different interventions in glaucoma patients versus controls

open access: yesScientific Reports
To evaluate reading performance patterns – specifically saccades, fixations, and reading speed – under three visual interventions (font size, line spacing, and contrast) in glaucoma patients compared to control subjects, using an eye tracker.
Mariana C. Ikeda   +9 more
doaj   +1 more source

Visual field global indices and heidelberg retinal tomograph II parameters after glaucoma surgery

open access: yes, 2008
Purpose: To detect and quantify changes in optic nerve morphology after glaucoma surgery, using Heidelberg Retina Tomograph (HRT), and in visual field global indices, using Humphrey perimeter.
Canovetti A   +4 more
core  

Infectious bacterial keratitis management in a Swedish region: Risk factors, treatment and time‐to‐resolution

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To report treatment patterns, time‐to‐resolution (TTR) and aetiologies of bacterial keratitis (BK) infections treated in a specialized hospital‐based cornea clinic in Sweden. Methods Retrospective study based on electronic health records screened during the period 2010–2019. The study included only culture‐confirmed cases of BK.
Jenny Roth   +5 more
wiley   +1 more source

Sustained intraocular pressure-lowering effect and biocompatibility of a single subconjunctival administration of hydrogel-encapsulated nano-brinzolamide

open access: yesJournal of Materials Science: Materials in Medicine
Brinzolamide is a widely used treatment for glaucoma, but its effectiveness relies on at least twice-daily dosing, which can be challenging for patient adherence.
Jiahao Xu   +6 more
doaj   +1 more source

Dry eye disease symptoms and associated risk factors in a Norwegian clinical cohort

open access: yesActa Ophthalmologica, EarlyView.
Abstract Background The relationship between dry eye disease (DED) symptoms and different demographic, clinical and lifestyle factors remains poorly understood. Norway's cold climate and dry indoor air may accelerate tear evaporation, contributing to a very high meibomian gland dysfunction prevalence, as found in multiple studies.
Mazyar Yazdani   +6 more
wiley   +1 more source

Patient‐reported outcomes and visual function after four refractive strategies in cataract surgery: A randomized controlled trial

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To evaluate patient‐reported outcome measures (PROMs) and visual function across four groups of public cataract patients: emmetropia, mini‐monovision, monovision with partial‐range of field (RoF) narrow intraocular lenses (IOLs) and patients implanted with partial‐RoF extended IOLs.
Anne Guldhammer Skov   +4 more
wiley   +1 more source

Adult‐onset Coats disease: A systematic review and meta‐analysis of imaging biomarkers and targeted therapies

open access: yesActa Ophthalmologica, EarlyView.
Abstract Coats disease diagnosed in adulthood is a rare idiopathic retinal telangiectatic vasculopathy that may differ in phenotype from childhood‐diagnosed cases. This systematic review synthesizes current evidence to characterize its clinical spectrum, imaging features, treatment outcomes and underlying mechanisms, with a focus on immunovascular ...
Catarina Francisco   +2 more
wiley   +1 more source

Corneal transplantation: Restoring sight to the blind

open access: yesActa Ophthalmologica, EarlyView.
Abstract Corneal blindness is one of the leading causes of vision loss worldwide. Transplantation of the cornea can restore vision and make blind patients see again. Corneal transplant surgery has undergone major evolution in recent decades with the advent of minimally invasive lamellar surgical approaches such as DMEK and DALK.
Claus Cursiefen
wiley   +1 more source

Home - About - Disclaimer - Privacy